Carfizome 60mg Injection is an anticancer medication containing the active constituent Carfilzomib. It is used to treat a type of cancer called multiple myeloma. Multiple myeloma is a cancer of a white blood cell called the plasma cell. These cells grow uncontrolled and accumulate in the bone marrow, damaging the bones and kidneys. The treatment with this medication reduces symptoms of multiple myelomas, such as bone pain, fatigue, and anemia, improving a patient's quality of life.

Combined with other medications, this medication can significantly increase survival rates in patients with multiple myeloma. It is often used in combination with other medications. Like all medications, it can have side effects. Common side effects include fatigue, nausea, vomiting, diarrhea, fever, and low blood cell counts. Patients need to stay hydrated while taking Carfizome 60mg Injection, as this medication causes dehydration, and dehydration can exacerbate some of the side effects of the medication. It effectively treats multiple myeloma, and the benefits may outweigh the risks for many patients.

Carfizome 60mg Injection is used to treat-

• Multiple myeloma

Carfizome 60mg Injection is a proteasome inhibitor, which means it works by blocking the action of proteasomes, the enzymes responsible for breaking down proteins in cells. By blocking proteasomes, this medication can prevent the growth and survival of cancer cells, ultimately leading to the death of cancer cells. This can help to slow or stop the progression of multiple myeloma and may improve survival rates for some patients.

Inform your healthcare provider about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Carfizome 60mg Injection and reduce effectiveness by causing undesirable side effects.

• Carfizome 60mg Injection should be stored under refrigeration between 2°C to 8°C (36°F to 46°F).
• Keep in the original package until it is ready to use.
• Should not be frozen.
• Discard any unused portion after 4 hours.
• Keep reaching out of children and pets.

Carfizome 60mg Injection is typically administered as an intravenous (IV) injection in a hospital or clinical setting by a healthcare provider. The exact dosing and frequency of administration will depend on the specific condition being treated and other individual factors, such as the patient's age, weight, and overall health. If a dose is missed, your healthcare provider as soon as possible to determine the appropriate course of action. Suppose the missed dose is discovered within a few hours of the scheduled time. In that case, your healthcare provider may recommend administering the missed dose as soon as possible. However, if more than a few hours have passed since the missed dose, your healthcare provider may recommend skipping the missed dose and resuming the regular dosing schedule at the next scheduled time. Should not double up on doses to make up for a missed one.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.

Serious:

• Cardiac events such as heart failure, heart attack, or arrhythmias
• Blood clotting disorders or bleeding
• Acute kidney injury
• Lung damage or inflammation
• Infections
• Tumor lysis syndrome (a condition that can occur when cancer cells break down rapidly)

Common side:

• Fatigue
• Nausea and vomiting
• Diarrhea
• Low blood cell counts (anemia, white blood cell count, platelet count)
• Fever
• Headache
• Difficulty breathing or shortness of breath
• Cough
• Muscle weakness or pain
• Rash
• Back pain

It is important to take the Carfizome 60mg Injection as directed by a healthcare professional. Patients should also inform their doctor of any pre-existing medical conditions and any other medications they may be taking. It is important to be aware of the potential side effects and to report any concerns to your healthcare provider. Pregnant or breastfeeding women should consult their doctor before taking it, as the drug may pose a risk to the baby. There are no specific dietary restrictions for patients taking this medication. However, it is generally recommended that patients with cancer maintain a healthy and balanced diet to support their overall health and well-being. Drinking plenty of water and other fluids, such as clear broths or herbal teas, can help to prevent dehydration.

1. Amgen Limited, Electronic medicines compendium (EMC), [Revised on August 2021] [ Accessed on 13th April 2023], https://www.medicines.org.uk/emc/files/pil.5061.pdf
2. Onyx Pharmaceuticals, Inc, US Food and Drug Administration, [Revised on Feb 2019] [ Accessed on 13th April 2023], 
3. Anderson KC, Munshi NC. Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders. New York: Springer; 2019.
4. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202714s025lbl.pdf
5. Kimberly Redic; Carfizome 60mg Injection: A novel agent for multiple myeloma; The Journal of Pharmacy and Pharmacology, [ Revised on Aug 2013], [Accessed on 13th April 2023] https://pubmed.ncbi.nlm.nih.gov/23837578/